Diabetes Enhanced

Northern Ireland

Date:

Part 1: 23rd September 2020 & Part 2: 21st October 2020

Cost:

Free

sponsor

Virtual Workshops – Type 2 Diabetes Enhanced Programme – Supporting GP Pharmacists already managing patients with Type 2 diabetes to Implement QI

The i2i Network is delighted to be continuing our collaboration with Napp Pharmaceuticals Limited to support GP Pharmacists by bringing an exciting programme designed to further develop competencies and skills in type 2 diabetes management.

These non-promotional webinars have been fully funded by Napp Pharmaceuticals Limited and organised by Soar Beyond. The agendas were developed by Soar Beyond in conjunction with Napp. Soar Beyond and the i2i faculty have developed the presentations independently from Napp, but Napp have reviewed the content for factual accuracy.

To learn more about how Napp protects your personal data, please refer to the Napp privacy notice by clicking here or copying and pasting the following link: https://napp.co.uk/privacy-notice/

Speakers

Philip Newland-Jones

Philip Newland-Jones is a Clinical Director, and a Consultant Pharmacist, in Diabetes and Endocrinology at University Hospitals Southampton NHS Foundation Trust. He is a current committee member of the UKCPA Diabetes and Endocrinology Group and Chairs the regional Diabetic subgroup of the District Prescribing Committee.

Read Bio
Hannah Beba

Hannah Beba is a Senior Pharmacist for Diabetes and Endocrinology at County Durham and Darlington NHS Foundation Trust. Hannah retains a predominantly clinical role and is an independent prescriber. Hannah has been independently practicing in clinics for many years in diabetes/endocrine across both primary and secondary care.

Read Bio
Niall O’Kane

Niall has been a qualified pharmacist for 16 years with just under 10 years working in primary care. He is currently the Lead General Practice Pharmacist for Mid Ulster. Niall initially specialised in hypertension before diverging to benzodiazepine reduction and osteoporosis. More recently Niall has evolved his role to include patients with Type 2 diabetes.

Read Bio

Agenda

By attending this live stream part 1, our expert speakers will explain and discuss:

1.  The impact and management of type 2 diabetes patients with a focus on co-morbid frailty, CKD and/or ASCVD

2. What quality improvement (QI) is and how to implement effective QI in practice for these patients

3. What to do in the Diagnose phase of QI using these patient cohorts

By attending this live stream part 2, our expert speakers will explain and discuss:

1.  Share outcomes and challenges from DIAGNOSE activities

2. Consider QI DESIGN options appraisal and DELIVER plans

3. DEMONSTRATE OUTCOMES- establishing QI process and patient impact

Supported by

sponsor

 

These non-promotional webinars have been fully funded by Napp Pharmaceuticals Limited and organised by Soar Beyond. The agendas were developed by Soar Beyond in conjunction with Napp. Soar Beyond and the i2i faculty have developed the presentations independently from Napp, but Napp have reviewed the content for factual accuracy.

To learn more about how Napp protects your personal data, please refer to the Napp privacy notice by clicking here or copying and pasting the following link: https://napp.co.uk/privacy-notice/

UK/DIA-20110b

  Date of Preparation September 2020

 

 

 

This workshop has already taken place.

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.